Skip to main content
Premium Trial:

Request an Annual Quote

Sage Science Inks Co-marketing Pact with Illumina

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sage Science said today that it will work with Illumina to co-market its automated gel technology with Illumina's next-generation sequencers.

The Beverly, Mass.-based firm said that the companies will co-market its Pippin Prep system for library size selection in sequencing projects.

The Pippin Prep automates size selection of DNA for library preparation in sequencing projects and is an alternative to manual gel extraction and purification, the company said. Sage Science said that using the Pippin Prep can enhance the sequence diversity and reduce low molecular weight contamination in sequencing libraries when compared to traditional gel methods.

As reported by GenomeWeb Daily News earlier today, Caliper Life Sciences also has signed a co-marketing pact with Illumina for gene sequencing and sample prep-related technologies.

Earlier this week, a similar sample prep-sequencing alliance was announced by Fluidigm and Roche 454 Life Sciences.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.